Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients
Several studies have linked bad prognoses of acute myeloid leukemia (AML) to the ability of leukemic cells to reprogram their metabolism and, in particular, their lipid metabolism. In this context, we performed “in-depth” characterization of fatty acids (FAs) and lipid species in leukemic cell lines...
Main Authors: | Caroline Lo Presti, Yoshiki Yamaryo-Botté, Julie Mondet, Sylvie Berthier, Denisa Nutiu, Cyrille Botté, Pascal Mossuz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/6/5988 |
Similar Items
-
Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts
by: Julie Mondet, et al.
Published: (2021-03-01) -
The Anti-Leukemic Activity of Natural Compounds
by: Coralia Cotoraci, et al.
Published: (2021-05-01) -
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients
by: Marianne Agerlund Petersen, et al.
Published: (2022-07-01) -
Metabolic Rewiring Is Essential for AML Cell Survival to Overcome Autophagy Inhibition by Loss of ATG3
by: Fatima Baker, et al.
Published: (2021-12-01) -
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
by: Matteo Molica, et al.
Published: (2022-06-01)